ePrints

British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017

Lookup NU author(s): Professor Hamish McAllister-WilliamsORCiD, Dr Eilish Gilvarry, Dr Laura YatesORCiD

Downloads

• Accepted version [.pdf]

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).

Abstract

© British Association for Psychopharmacology. Decisions about the use of psychotropic medication in pregnancy are an ongoing challenge for clinicians and women with mental health problems, owing to the uncertainties around risks of the illness itself to mother and fetus/infant, effectiveness of medications in pregnancy and risks to the fetus/infant from in utero exposure or via breast milk. These consensus guidelines aim to provide pragmatic advice regarding these issues. They are divided into sections on risks of untreated illness in pregnancy; general principles of using drugs in the perinatal period; benefits and harms associated with individual drugs; and recommendations for the management of specific disorders.

Publication metadata

Author(s): Mcallister-Williams RH, Baldwin DS, Cantwell R, Easter A, Gilvarry E, Glover V, Green L, Gregoire A, Howard LM, Jones I, Khalifeh H, Lingford-Hughes A, McDonald E, Micali N, Pariante CM, Peters L, Roberts A, Smith NC, Taylor D, Wieck A, Yates LM, Young AH

Publication type: Article

Publication status: Published

Journal: Journal of Psychopharmacology

Year: 2017

Volume: 31

Issue: 5

Pages: 519-552

Online publication date: 25/04/2017

Acceptance date: 02/04/2016

Date deposited: 03/07/2017

ISSN (print): 0269-8811

ISSN (electronic): 1461-7285

Publisher: Sage Publications Ltd

URL: https://doi.org/10.1177/0269881117699361

DOI: 10.1177/0269881117699361

Altmetrics

Share